Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.18.435972Source: DataRank Database

A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 49 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access49 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (22)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (35)

Manon Nayrac ORCID,Mehdi Benlarbi ORCID,Shang Yu Gong ORCID,Romain Gasser ORCID,Guillaume Beaudoin-Bussières ORCID

Live enrichment

PubMed:33758857 OpenAlex:https://openalex.org/W3136620215

NIAID NIH HHS

Grant: UM1 AI144462

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/03/18/2021.03.18.435972.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.03.18.435972

repositoryhttps://doi.org/10.1101/2021.03.18.435972

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33758857

Fields of Study

SARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchViral gastroenteritis research and epidemiology

Keywords

AntibodyVaccine trialImmunologyEffectorContext (archaeology)Vaccine efficacyPopulationNeutralizing antibodyMedicineVirologyImmunityHumoral immunityPotencyDosingBiologyImmune systemPharmacologyIn vitroGenetics

Sustainable Development Goals

SDG 0: Good health and well-being